The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|October 16, 2017
Croda Showcases High-Purity Pharma Excipients at CPhI Worldwide 2017
Author(s)Pharmaceutical Technology Editors
Croda is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance.
Advertisement
Croda, a supplier of natural-based specialty chemicals, is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance at CPhI Worldwide 2017. The company has manufacturing facilities around the globe.
Experts from Croda will be available to talk about the benefits of high-purity pharmaceutical ingredients for multiple drug administration routes, including the parenteral, ophthalmic, oral, and topical routes.
Visitor can visit Croda at CPhI to learn more about:
- Improved API stability
- Reduced cellular irritation
- Increased API delivery
- Accelerated speed to market
- Reducing drug development times
- Simplifying formulations
Source: Croda, Stand 102B11
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
2
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
3
PharmTech Weekly Roundup—October 23, 2026: CMC Considerations, Rare Disease Development, Standards Harmonization
4
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
5